Active, not recruitingPhase 2NCT04974008

Osteosarcoma Maintenance Therapy With OST31-164

Studying Bone sarcoma

Last synced from ClinicalTrials.gov May 5, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Emerald Clinical Inc.
Principal Investigator: Robert Petit, PhD
OS Therapies, Inc.
Intervention: OST31-164(drug)
Enrollment: 39 target
Eligibility: 12-39 years · All sexes
Timeline: 2021 – 2027

Study locations (21)

Kaiser Permanente Downey Medical Center, Los Angeles, California, United States
Children's Hospital of Orange County, Orange, California, United States
Rady Children's Hospital, San Diego, California, United States
Children's Hospital of Colorado, Aurora, Colorado, United States
Connecticut Children's, Hartford, Connecticut, United States
Nemours/ Alfred I duPont Hospital for Children, Wilmington, Delaware, United States
Johns Hopkins All Children's Hospital, St. Petersburg, Florida, United States
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
Johns Hopkins Medical Center, Baltimore, Maryland, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, United States
Hackensack University Medical Center, Hackensack, New Jersey, United States
Montefiore Medical Center, The Bronx, New York, United States
Nationwide Children's Hospital, Columbus, Ohio, United States
+6 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04974008 on ClinicalTrials.gov

Other trials for Bone sarcoma

Additional recruiting or active studies for the same condition.

See all trials for Bone sarcoma →

← Back to all trials